Informations:
Erreur:
ID
21430
Description
Fludarabine and Cyclophosphamide With or Without Rituximab in Treating Patients With Previously Untreated Mantle Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00641095
Lien
https://clinicaltrials.gov/show/NCT00641095
Mots-clés
Versions (1)
- 21/04/2017 21/04/2017 -
Téléchargé le
21 avril 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Lymphoma NCT00641095
Eligibility Lymphoma NCT00641095
- StudyEvent: Eligibility
Similar models
Eligibility Lymphoma NCT00641095
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Mantle cell lymphoma
Item
histologically confirmed mantle cell lymphoma (mcl), meeting the following criteria:
boolean
C0334634 (UMLS CUI [1])
Examination of lymph nodes or bone marrow and immunophenotype
Item
diagnosis confirmed by examination of representative material (lymph nodes or bone marrow) together with a typical immunophenotype cd5+, cd23-, sigm, cyclin d1 nuclear positivity is desirable but not essential
boolean
C0024204 (UMLS CUI [1])
C1550653 (UMLS CUI [2])
C0079611 (UMLS CUI [3])
C1550653 (UMLS CUI [2])
C0079611 (UMLS CUI [3])
Histological finding
Item
central review of histology will be performed on diagnostic material
boolean
C0449575 (UMLS CUI [1])
Molecular or cytogenetic confirmation
Item
molecular or cytogenetic confirmation of diagnosis is not required
boolean
C1513388 (UMLS CUI [1])
C0010802 (UMLS CUI [2])
C0010802 (UMLS CUI [2])
Untreated disease requiring therapy
Item
previously untreated disease at any stage requiring therapy in the opinion of the treating physician
boolean
C0332155 (UMLS CUI [1,1])
C1830593 (UMLS CUI [1,2])
C1830593 (UMLS CUI [1,2])
Patient characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Life expectancy
Item
life expectancy ≥ 3 months
boolean
C0023671 (UMLS CUI [1])
Comorbidity affecting life expectancy
Item
life expectancy not severely limited by other illness
boolean
C0009488 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0023671 (UMLS CUI [1,3])
C0392760 (UMLS CUI [1,2])
C0023671 (UMLS CUI [1,3])
Creatinine clearance
Item
creatinine clearance ≥ 30 ml/min
boolean
C0373595 (UMLS CUI [1])
Gynaecological status
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Pregnancy test
Item
negative pregnancy test
boolean
C0032976 (UMLS CUI [1])
Contraceptive methods
Item
fertile patients must use effective contraception during study therapy
boolean
C0700589 (UMLS CUI [1])
HBV, HCV, HIV serology
Item
no known serological positivity for hbv, hcv, or hiv
boolean
C0744837 (UMLS CUI [1])
C0850489 (UMLS CUI [2])
C0019699 (UMLS CUI [3])
C0850489 (UMLS CUI [2])
C0019699 (UMLS CUI [3])
Uncontrolled comorbidity
Item
no concurrent uncontrolled serious medical conditions
boolean
C0205318 (UMLS CUI [1,1])
C0009488 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,2])
Renal or liver function
Item
no severe impairment of renal or liver function (alkaline phosphatase, bilirubin or creatinine > 2.5 times upper limit of normal) not related to lymphoma
boolean
C0232804 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232741 (UMLS CUI [2])
Hypersensitivity to murine proteins
Item
no known hypersensitivity to murine proteins
boolean
C0020517 (UMLS CUI [1,1])
C1699668 (UMLS CUI [1,2])
C1699668 (UMLS CUI [1,2])
Prior malignancy
Item
no prior malignancy in the past 5 years, except for nonmelanoma skin tumor or curatively resected carcinoma in situ of the uterine cervix
boolean
C2735088 (UMLS CUI [1])
Compliance
Item
no history of a psychological illness or condition that, in the opinion of the investigator, may adversely affect compliance with study medication
boolean
C1321605 (UMLS CUI [1])
Concurrent therapy
Item
prior concurrent therapy:
boolean
C0009429 (UMLS CUI [1])
Prior chemotherapy
Item
no prior chemotherapy
boolean
C1514457 (UMLS CUI [1])